Par Pharmaceutical: Par launches generic Pylera
The drug is used to treat patients with Helicobacter pylori infection and duodenal ulcer disease to eradicate H. pylori.
Read full article »
CEO
Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States.
Read more